syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.5181308000000002	100.0
CRANIOSYNOSTOSIS 4; CRS4	1.50613497	99.20982895544968
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.80571555494426
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.99757016984306
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0311747820000001	67.92397479848245
AURICULOOSTEODYSPLASIA	1.0232558	67.40234767649797
THYROTROPIN-RELEASING HORMONE DEFICIENCY	1.0	65.87047703662951
TRICHODENTOOSSEOUS SYNDROME	1.0	65.87047703662951
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.87047703662951
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	62.47239038955008
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	42.08389685526438
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.42329699127373
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.529420522	34.873182337121406
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	34.17807609199418
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.90392316656773
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.504552111	33.23508824140844
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.99082542821738
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	32.99082542821738
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.935238518314755
COMBINED SAPOSIN DEFICIENCY	0.5	32.935238518314755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.935238518314755
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.935238518314755
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.49156134300000004	32.37938015617626
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48869108200000005	32.19031469488663
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	30.719941918048164
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	29.537151871235334
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	29.537151871235334
CENTRALOPATHIC EPILEPSY	0.44841259999999994	29.537151871235327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.38390754	25.288172797758925
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.19405442534991
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.19405442534991
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.719464225348695
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.719464225348695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.37227752199999997	24.522097964154334
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.80240226994933
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.690238021651357
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.353044782	23.25522820563287
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	23.041616835650785
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.925488370303793
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	21.78664592010122
TUBEROUS SCLEROSIS	0.32591575100000003	21.46822599212136
AICARDI SYNDROME; AIC	0.325	21.40790503690459
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.31720818200000006	20.894654268262
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.285157582	18.783465956951797
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.276177622	18.191951707981946
DYSTONIA 6, TORSION	0.275	18.114381185073118
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.43630390741035
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.257050721	16.932053614879557
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25363636	16.707148027034297
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.250843882	16.523206169060003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	16.467619259157377
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.467619259157377
OTOFACIOCERVICAL SYNDROME 2	0.25	16.467619259157377
HYPEREKPLEXIA 1; HKPX1	0.25	16.467619259157377
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.467619259157377
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.467619259157377
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.467619259157377
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	16.467619259157377
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.467619259157377
NIJMEGEN BREAKAGE SYNDROME	0.25	16.467619259157377
HYPERPARATHYROIDISM 2	0.25	16.467619259157377
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.78318600742439
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.78318600742439
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.78318600742439
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.78318600742439
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.78318600742439
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.210552622	13.869201652453134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.20412282199999998	13.445667659203012
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	13.229682317228528
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.997871461405037
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.942284551502413
CHROMOSOME 1P36 DELETION SYNDROME	0.17109668299999997	11.270220128594977
TURNPENNY-FRY SYNDROME; TPFS	0.16327068199999997	10.754717709435837
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.15608352199999997	10.281296051697256
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.14583517299999998	9.60623241422939
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.465645647924404
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.13964563	9.19852426418066
611961 STEVENSON-CAREY SYNDROME	0.13612643299999996	8.966713079004784
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.13507198	8.89725575688208
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.854605940410403
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	8.842343031311927
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.72643516619253
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.13197885199999998	8.693509939986724
#602398 DESMOSTEROLOSIS	0.130016963	8.56427937566381
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.12893701	8.49314235637667
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.12825733	8.448371510544412
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.29413058479546
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.125915751	8.29413058479546
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.29413058479546
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	8.289396539481313
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.282810677446237
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.125	8.233809629578689
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.125	8.233809629578689
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.125	8.233809629578689
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.118848572	7.828612132762208
MOWAT-WILSON SYNDROME; MOWS	0.115663111	7.61878429711063
BAKER-GORDON SYNDROME; BAGOS	0.115212212	7.5890833648852905
POTOCKI-LUPSKI SYNDROME	0.112870633	7.434842439136337
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.11195488199999999	7.374521483919566
THREE M SYNDROME 2; 3M2	0.11111099999999999	7.31893457401694
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.121171640809869
WHITE-SUTTON SYNDROME; WHSUS	0.10478089200000001	6.901967340363557
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.6473686588797225
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.587047703662952
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.587047703662952
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.587047703662952
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.587047703662952
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.587047703662952
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09663488200000002	6.365385775718403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09424668200000001	6.208073902459525
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.91066006960665
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.850339114389879
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.08800637	5.79702157416212
CANAVAN DISEASE	0.08663184000000002	5.706480627360963
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.08271528200000001	5.448495083559335
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.08225804200000002	5.418376466639107
WITTEVEEN-KOLK SYNDROME	0.08112257300000002	5.343582581948802
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	5.195132066354229
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.14613101848668
LISSENCEPHALY 2; LIS2	0.07776698200000001	5.122548202038981
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07776698200000001	5.122548202038981
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.066961292136356
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.066961292136356
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.07692310000000001	5.066961292136356
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.066961292136356
MYOCLONUS AND ATAXIA	0.07692310000000001	5.066961292136356
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.07635848199999999	5.0297696351328876
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.902311447735597
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.902311447735597
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.07417458200000002	4.885915100332594
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.07105568200000001	4.680471669503049
Helsmoortel-van der Aa syndrome	0.07035446300000002	4.634282039465902
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.628158522309144
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.628158522309144
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.067419322	4.440942901626131
LUSCAN-LUMISH SYNDROME; LLS	0.06671810300000001	4.394753271588983
15q26 overgrowth syndrome	0.06639687000000001	4.373593500639076
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.226447418101259
Retinitis pigmentosa with or without skeletal anomalies	0.063604392	4.189651642664781
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.063303742	4.169847683743718
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	4.165905862656893
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	4.165905862656893
MENTAL RETARDATION, X-LINKED 98; MRX98	0.062568333	4.121405942096688
OROFACIAL CLEFT 15	0.062080830000000004	4.089293886929901
NOONAN SYNDROME 4; NS4	0.062080830000000004	4.089293886929901
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.060583133	3.9906398710835713
Pierpont syndrome	0.060583133	3.9906398710835713
WIEACKER-WOLFF SYNDROME	0.060583133	3.9906398710835713
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9449565215329265
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.059667382	3.9303189158668004
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.059667382	3.9303189158668004
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.05949261	3.918806600854155
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0588235	3.8747320059641757
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.0588235	3.8747320059641757
CHROMOSOME 17q12 DELETION SYNDROME	0.058812930000000006	3.8740357550218993
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.7313451515508413
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.7197948292729452
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.715060783958799
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.6594738740561747
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.6594738740561747
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.6594738740561747
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.6594738740561747
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	3.6594738740561747
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.6594738740561747
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.6594738740561747
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.05177003	3.4101165723006206
HAREL-YOON SYNDROME; HAYOS	0.050415482	3.3208918493716078
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.3131290795233186
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.050297633	3.3131290795233186
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.296335335532353
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0495716	3.2653049394689835
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.1972212144039234
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.1972212144039234
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0482558	3.178632565784186
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.048101572999999995	3.1684735597222575
ZUNICH NEUROECTODERMAL SYNDROME	0.048012150999999996	3.1625832899246884
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.044724969999999996	2.946055109348943
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.044126422	2.906628467059623
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.043985992999999994	2.897378341839846
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0431818	2.844405765300328
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682000000004	2.818247413200496
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.04269121199999999	2.8120904997118816
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.7577058577561298
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7577058577561298
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.702118947853505
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.040549782	2.6710334840713323
CORNELIA DE LANGE SYNDROME 3	0.03976438299999999	2.6192988772772408
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.039433881999999996	2.5975286187461575
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.039084703	2.5745280314449843
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.038848631999999994	2.55897792206047
THUMBS, CONGENITAL CLASPED	0.0384757	2.5344127133182464
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.038468191	2.5339180919061777
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.03800475	2.503391012157845
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.037990381999999996	2.502444585143783
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.037467732999999996	2.4680174461910656
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.036988912	2.43647727850591
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.432471563056358
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.432471563056358
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.036674582	2.415772211458986
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.036623851	2.4124305362884404
HAMAMY SYNDROME; HMMS	0.0366009	2.4109187429699728
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.036468373	2.4021891262597395
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.03608713	2.377076467982864
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.036024703	2.372964371712898
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.035860500999999996	2.362148307642529
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.034786763	2.291420673370173
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.034454382	2.269526578342261
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.2671091318350167
COFFIN-SIRIS SYNDROME 6; CSS6	0.034354022	2.262915817266865
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.033743181	2.2226794292033327
AL KAISSI SYNDROME; ALKAS	0.033653323	2.216760439877776
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.2115222219323916
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.033294652	2.193134610008571
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.032998533	2.173629110218961
ROIFMAN SYNDROME; RFMN	0.032941031999999995	2.1698414919188775
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.032767373	2.158402490747174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.032677852	2.1525056997723775
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.032450770000000004	2.1375477001059457
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.032126210999999995	2.116168843949414
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.032063621	2.1120460107916914
Muenke syndrome	0.032012443	2.108674891517911
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.031909123000000005	2.101869153830487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.031711792999999995	2.0888709325968478
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.031332763	2.0639040456856548
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.031332763	2.0639040456856548
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.031332763	2.0639040456856548
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.031332763	2.0639040456856548
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.031174781999999998	2.0534977618529306
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.031150403	2.051891905493255
Temtamy preaxial brachydactyly syndrome	0.031096692000000002	2.0483539363011407
RAINE SYNDROME	0.031096692000000002	2.0483539363011407
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.030867910999999998	2.0332840226942235
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.030417012	2.0035830904688843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.030336273	1.9982647740234238
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0303309	1.9979108519503062
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9979108519503062
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9979108519503062
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9979108519503062
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.030306521	1.9963049955906298
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.03025281	1.9927670263985158
FACIOCARDIORENAL SYNDROME	0.02995216	1.972963067477453
CHROMOSOME 3q13.31 DELETION SYNDROME	0.02957313	1.9479961805662593
3MC SYNDROME 2	0.029480242000000004	1.9418776036952812
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.029420522	1.9379438188066533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.029420522	1.9379438188066533
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.029420522	1.9379438188066533
FRANK-TER HAAR SYNDROME; FTHS	0.02939077	1.9359840403738595
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02857664	1.8823569089040284
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.02857664	1.8823569089040284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.02857664	1.8823569089040284
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.028302802999999998	1.8643191350837487
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.028272763	1.8623403859535683
KOOLEN-DE VRIES SYNDROME; KDVS	0.028272763	1.8623403859535683
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.028272763	1.8623403859535683
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.028217640999999995	1.8587094735183551
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.028075433	1.8493421647199304
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.028075433	1.8493421647199304
KLEEFSTRA SYNDROME 2; KLEFS2	0.028075433	1.8493421647199304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.028075433	1.8493421647199304
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.028075433	1.8493421647199304
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.027736042000000002	1.826986317647992
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.027574099999999997	1.8163191208557257
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.027231551	1.7937552548173055
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.027231551	1.7937552548173055
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.02719281	1.7912033666664293
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.78902120950316
CRANIOSYNOSTOSIS 6; CRS6	0.027159682	1.78902120950316
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.78902120950316
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.78902120950316
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.027093373	1.7846534040413378
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.027003092000000003	1.7787065515039941
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.02689216	1.7713994077453665
TEMPLE SYNDROME	0.026543169999999998	1.748411269964353
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.7334342996005347
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.7334342996005347
ROBINOW-SORAUF SYNDROME	0.0263158	1.7334342996005347
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.7334342996005347
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.025933739999999997	1.70826782514392
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.025933739999999997	1.70826782514392
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.025919371999999996	1.7073213981298578
KUFOR-RAKEB SYNDROME	0.025915751	1.7070828811325083
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.025858560000000003	1.7033156826803064
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.025843882000000002	1.702348835818363
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.025804192999999996	1.6997345024552555
ACROCALLOSAL SYNDROME; ACLS	0.025633361	1.6884817171221347
INFANTILE SIALIC ACID STORAGE DISEASE	0.025425162999999997	1.674767615544062
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.025232520999999997	1.6620781951067716
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.025232520999999997	1.6620781951067716
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.025015433	1.647778504987844
PRADER-WILLI SYNDROME; PWS	0.025015433	1.647778504987844
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.025015433	1.647778504987844
DYSTONIA 11, MYOCLONIC	0.025	1.646761925915738
DYSTONIA 13, TORSION	0.025	1.646761925915738
TORTICOLLIS	0.025	1.646761925915738
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.025	1.646761925915738
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.025	1.646761925915738
DYSTONIA 7, TORSION	0.025	1.646761925915738
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.025	1.646761925915738
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.025	1.646761925915738
DYSTONIA 23; DYT23	0.025	1.646761925915738
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.025	1.646761925915738
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.025	1.646761925915738
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.025	1.646761925915738
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.025	1.646761925915738
#615034 DYSTONIA 24; DYT24	0.025	1.646761925915738
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.025	1.646761925915738
BETHLEM MYOPATHY 1	0.025	1.646761925915738
DYSTONIA 12; DYT12	0.025	1.646761925915738
DYSTONIA 21; DYT21	0.025	1.646761925915738
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.025	1.646761925915738
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.025	1.646761925915738
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.025	1.646761925915738
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.025	1.646761925915738
DYSTONIA 26, MYOCLONIC; DYT26	0.025	1.646761925915738
DYSTONIA, DOPA-RESPONSIVE; DRD	0.025	1.646761925915738
Ullrich congenital muscular dystrophy 1	0.025	1.646761925915738
DYSTONIA 25	0.025	1.646761925915738
ACERULOPLASMINEMIA	0.025	1.646761925915738
#118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8	0.025	1.646761925915738
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.025	1.646761925915738
COSTELLO SYNDROME; CSTLO	0.024509411999999998	1.6144466603272918
KNIEST-LIKE DYSPLASIA, LETHAL	0.02434521	1.603630596256923
CORNEODERMATOOSSEOUS SYNDROME	0.02434521	1.603630596256923
ATELOSTEOGENESIS, TYPE I; AO1	0.02434521	1.603630596256923
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.024316769999999998	1.601757239890001
SECKEL SYNDROME 7; SCKL7	0.024171551	1.592191595085219
AU-KLINE SYNDROME; AUKS	0.024099682	1.5874575497710737
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.024099682	1.5874575497710737
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.024099682	1.5874575497710737
Diamond-Blackfan anemia 1	0.023665529999999997	1.5588597504246666
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.023665529999999997	1.5588597504246666
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0232558	1.5318706398684485
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0232558	1.5318706398684485
CRANIOECTODERMAL DYSPLASIA 4	0.0232558	1.5318706398684485
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.0232558	1.5318706398684485
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0232558	1.5318706398684485
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0232558	1.5318706398684485
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0232558	1.5318706398684485
HIP DYSPLASIA, BEUKES TYPE	0.0232558	1.5318706398684485
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.0232558	1.5318706398684485
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0232558	1.5318706398684485
MEIER-GORLIN SYNDROME 6; MGORS6	0.0232558	1.5318706398684485
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0232558	1.5318706398684485
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.0232558	1.5318706398684485
#613618 CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME	0.0232558	1.5318706398684485
BEEMER LETHAL MALFORMATION SYNDROME	0.02324416	1.5311039075157422
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.023198762999999997	1.52811358546971
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.023198762999999997	1.52811358546971
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.023198762999999997	1.52811358546971
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.023137951	1.5241078700201587
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5193738247060133
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.023066082	1.5193738247060133
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.5193738247060133
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5193738247060133
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.023034561	1.5172975213993416
RING CHROMOSOME 14 SYNDROME	0.022969112	1.5129863645477712
Congenital disorder of glycosylation, type IIh	0.022969112	1.5129863645477712
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.022969112	1.5129863645477712
PEHO-LIKE SYNDROME; PEHOL	0.022969112	1.5129863645477712
MEGAEPIPHYSEAL DWARFISM	0.02286513	1.5061370206045486
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02280491	1.5021703004774027
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.022540233	1.4847359002267786
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.022540233	1.4847359002267786
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.022504259999999998	1.48236634155634
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.022504259999999998	1.48236634155634
DIAPHANOSPONDYLODYSOSTOSIS	0.022283011999999998	1.4677926302529396
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4637869148033884
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4637869148033884
EPILEPSY, HOT WATER, 1	0.0222222	1.4637869148033884
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4637869148033884
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4637869148033884
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4637869148033884
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0222222	1.4637869148033884
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.022167832999999998	1.4602057345783377
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.022167832999999998	1.4602057345783377
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.022167832999999998	1.4602057345783377
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.022167832999999998	1.4602057345783377
KAGAMI-OGATA SYNDROME	0.022167832999999998	1.4602057345783377
MECKEL SYNDROME 12; MKS12	0.021818159999999996	1.437172607261508
PALLISTER-KILLIAN SYNDROME	0.021696351000000003	1.4291489903241539
PELGER-HUET ANOMALY; PHA	0.021684751999999998	1.4283849586610058
ACRORENAL-MANDIBULAR SYNDROME	0.021439129999999997	1.4122057203503147
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.021439129999999997	1.4122057203503147
BAND HETEROTOPIA; BH	0.021367433	1.4074830047582196
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.021367433	1.4074830047582196
GAUCHER DISEASE, PERINATAL LETHAL	0.021323950999999997	1.4046188246757125
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.4046188246757125
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021252082	1.3998847793615672
TYSHCHENKO SYNDROME	0.021252082	1.3998847793615672
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.021252082	1.3998847793615672
HYPERPROLINEMIA, TYPE I	0.020627533	1.3587454387988174
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.020624602000000002	1.3585523724306232
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.020523551	1.3518960948555947
COPPER DEFICIENCY, FAMILIAL BENIGN	0.020523551	1.3518960948555947
HHHH SYNDROME	0.020523551	1.3518960948555947
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.3442978694589423
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.3442978694589423
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.3442978694589423
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.020408199999999998	1.3442978694589423
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	1.3442978694589423
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	1.3442978694589423
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.3442978694589423
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.3442978694589423
RESTRICTIVE DERMOPATHY, LETHAL	0.020408199999999998	1.3442978694589423
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.3442978694589423
NEMALINE MYOPATHY 10	0.020408199999999998	1.3442978694589423
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.3442978694589423
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.3442978694589423
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	1.3442978694589423
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.020408199999999998	1.3442978694589423
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	1.3442978694589423
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	1.3442978694589423
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.3442978694589423
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	1.3442978694589423
YUNIS-VARON SYNDROME	0.020408199999999998	1.3442978694589423
ROIFMAN-CHITAYAT SYNDROME	0.020105242000000002	1.3243418814768793
ADAMS-OLIVER SYNDROME 2; AOS2	0.019941432999999998	1.3135517045039857
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.019941432999999998	1.3135517045039857
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.2984244835820469
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.2984244835820469
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.2984244835820469
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	1.2984244835820469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.2984244835820469
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019711782	1.2984244835820469
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	1.2984244835820469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.019711782	1.2984244835820469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.019711782	1.2984244835820469
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	1.2984244835820469
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	1.2984244835820469
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	1.2984244835820469
FUMARASE DEFICIENCY; FMRD	0.019711782	1.2984244835820469
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019711782	1.2984244835820469
THALIDOMIDE SUSCEPTIBILITY	0.0196078	1.2915751396388242
THROMBOCYTOPENIA 3	0.0196078	1.2915751396388242
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	1.2915751396388242
VAN DEN BOSCH SYNDROME	0.0196078	1.2915751396388242
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	1.2915751396388242
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	1.2915751396388242
PACHYDERMODACTYLY, FAMILIAL	0.0196078	1.2915751396388242
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	1.2915751396388242
#215300 CHONDROSARCOMA	0.0196078	1.2915751396388242
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	1.2915751396388242
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	1.2915751396388242
LETTERER-SIWE DISEASE	0.0196078	1.2915751396388242
TOE, MISSHAPEN	0.0196078	1.2915751396388242
SPINAL ARACHNOIDITIS	0.0196078	1.2915751396388242
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	1.2915751396388242
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	1.2915751396388242
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	1.2915751396388242
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	1.2915751396388242
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	1.2915751396388242
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	1.2915751396388242
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	1.2915751396388242
DOUBLE NAIL FOR FIFTH TOE	0.0196078	1.2915751396388242
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	1.2915751396388242
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	1.2915751396388242
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	1.2915751396388242
MONOPHALANGY OF GREAT TOE	0.0196078	1.2915751396388242
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	1.2915751396388242
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	1.2915751396388242
TRACHEOBRONCHOMEGALY	0.0196078	1.2915751396388242
NEPHROSIALIDOSIS	0.0196078	1.2915751396388242
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	1.2915751396388242
RAYNAUD DISEASE	0.0196078	1.2915751396388242
VESICOURETERAL REFLUX 1	0.0196078	1.2915751396388242
KNUCKLE PADS	0.0196078	1.2915751396388242
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	1.2915751396388242
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	1.2915751396388242
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	1.2915751396388242
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	1.2915751396388242
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	1.2915751396388242
PUBIC BONE DYSPLASIA	0.0196078	1.2915751396388242
CARPAL DISPLACEMENT	0.0196078	1.2915751396388242
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	1.2915751396388242
PETERS-PLUS SYNDROME; PTRPLS	0.019583553	1.2899779781821168
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.019261359999999998	1.268754971574254
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.019097550999999997	1.2579647946013608
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.019025682	1.2532307492872152
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.019025682	1.2532307492872152
EVEN-PLUS SYNDROME	0.019025682	1.2532307492872152
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	1.242837573679422
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.242837573679422
MYOPATHY, CONGENITAL	0.0188679	1.242837573679422
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.242837573679422
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.242837573679422
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.242837573679422
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.242837573679422
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.242837573679422
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.242837573679422
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.242837573679422
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.242837573679422
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.242837573679422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	1.242837573679422
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.242837573679422
DIASTEMATOMYELIA	0.0188679	1.242837573679422
RHEUMATOID ARTHRITIS	0.0188679	1.242837573679422
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.242837573679422
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.242837573679422
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.242837573679422
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.242837573679422
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	1.242837573679422
CERVICAL RIB	0.0188679	1.242837573679422
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.242837573679422
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.242837573679422
269800 SENILE PLAQUE FORMATION	0.0188679	1.242837573679422
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.242837573679422
TRANSSEXUALITY	0.0188679	1.242837573679422
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.242837573679422
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.242837573679422
MOTION SICKNESS	0.0188679	1.242837573679422
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.242837573679422
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.242837573679422
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.242837573679422
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	1.242837573679422
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.242837573679422
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.242837573679422
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.242837573679422
CARDIAC ARRHYTHMIA	0.0188679	1.242837573679422
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.242837573679422
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.242837573679422
JUMPING FRENCHMAN OF MAINE	0.0188679	1.242837573679422
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.242837573679422
ALCOHOL DEPENDENCE	0.0188679	1.242837573679422
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.242837573679422
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.242837573679422
ERYTHERMALGIA, PRIMARY	0.0188679	1.242837573679422
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.242837573679422
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.242837573679422
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.242837573679422
PALMOMENTAL REFLEX	0.0188679	1.242837573679422
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.242837573679422
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.242837573679422
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.242837573679422
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.242837573679422
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.242837573679422
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.018367151999999998	1.2098530640442835
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.018181799999999998	1.1976438393845903
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.018181799999999998	1.1976438393845903
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.018181799999999998	1.1976438393845903
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.018181799999999998	1.1976438393845903
HEMOCHROMATOSIS, NEONATAL	0.018181799999999998	1.1976438393845903
FONTAINE PROGEROID SYNDROME; FPS	0.018181799999999998	1.1976438393845903
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.018181799999999998	1.1976438393845903
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.018181799999999998	1.1976438393845903
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.018181799999999998	1.1976438393845903
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.018181799999999998	1.1976438393845903
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.018181799999999998	1.1976438393845903
#615397 MECKEL SYNDROME, TYPE 11; MKS11	0.018181799999999998	1.1976438393845903
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.018181799999999998	1.1976438393845903
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.018181799999999998	1.1976438393845903
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.018181799999999998	1.1976438393845903
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.018181799999999998	1.1976438393845903
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.018181799999999998	1.1976438393845903
TRANSALDOLASE DEFICIENCY	0.018181799999999998	1.1976438393845903
COLE-CARPENTER SYNDROME 2; CLCRP2	0.018181799999999998	1.1976438393845903
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.018181799999999998	1.1976438393845903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.018181799999999998	1.1976438393845903
MECKEL SYNDROME, TYPE 1; MKS1	0.018181799999999998	1.1976438393845903
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.018181799999999998	1.1976438393845903
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.017603343	1.159540600849413
METAPHYSEAL ACROSCYPHODYSPLASIA	0.016965670000000002	1.1175367761460342
DYSOSTEOSCLEROSIS	0.016759461	1.103953690946788
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.0895471589141066
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.0895471589141066
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.084813113599961
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016468882	1.084813113599961
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.084813113599961
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	1.084813113599961
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.084813113599961
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	1.084813113599961
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.084813113599961
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.084813113599961
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016468882	1.084813113599961
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.084813113599961
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	1.084813113599961
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.084813113599961
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.084813113599961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.016468882	1.084813113599961
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.016405263000000003	1.080622499721368
WIEDEMANN-STEINER SYNDROME; WDSTS	0.016405263000000003	1.080622499721368
PHELAN-MCDERMID SYNDROME; PHMDS	0.016405263000000003	1.080622499721368
CRANIOFRONTONASAL SYNDROME; CFNS	0.016169192	1.0650723903368535
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.015625	1.029226203697336
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.029226203697336
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.029226203697336
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.029226203697336
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.029226203697336
HYDROXYLYSINURIA	0.015625	1.029226203697336
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	1.029226203697336
MICROHYDRANENCEPHALY; MHAC	0.015625	1.029226203697336
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.029226203697336
PAINE SYNDROME	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	1.029226203697336
CARNOSINEMIA	0.015625	1.029226203697336
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	1.029226203697336
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	1.029226203697336
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.029226203697336
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.0290056034697403
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.0290056034697403
OHDO SYNDROME	0.015561381	1.0250355898187429
RENPENNING SYNDROME 1; RENS1	0.015561381	1.0250355898187429
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.015561381	1.0250355898187429
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	1.0242715581555948
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015549782	1.0242715581555948
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	1.0242715581555948
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.0242715581555948
ZTTK SYNDROME; ZTTKS	0.015104733	0.9949559682209199
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.015088943	0.9939158733885116
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01494628	0.984518593523035
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01494628	0.984518593523035
JACOBSEN SYNDROME	0.01494628	0.984518593523035
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.014788293000000001	0.9741119144674489
LARSEN-LIKE SYNDROME	0.014730792	0.9703242961673656
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.014725703000000001	0.9699890813097264
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.014725703	0.9699890813097263
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.96868464825297
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.96868464825297
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.96868464825297
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.96868464825297
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.96868464825297
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.96868464825297
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.96868464825297
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.96868464825297
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.96868464825297
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.96868464825297
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.96868464825297
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.96868464825297
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.96868464825297
HALLERMANN-STREIFF SYNDROME; HSS	0.0147059	0.96868464825297
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.96868464825297
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.96868464825297
DUBOWITZ SYNDROME	0.01464563	0.9647146346019722
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.014260851	0.939369058318295
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.014173192000000001	0.9335949181717411
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.013944411	0.9185250045648239
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.013872542	0.9137909592506784
OGDEN SYNDROME; OGDNS	0.013872542	0.9137909592506784
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.013872542	0.9137909592506784
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.013872542	0.9137909592506784
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.013448583	0.885864577676706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.013147933	0.8660606187556433
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01302866	0.8582040493480534
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.012768903000000002	0.8410937318444497
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.012604701	0.830277667774081
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.012590333	0.8293312407600186
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.012532832	0.8255436224599354
%300712 CRANIOFACIOSKELETAL SYNDROME	0.012532832	0.8255436224599354
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.012532832	0.8255436224599354
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.012532832	0.8255436224599354
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.012232182	0.8057396635388727
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.011853152	0.7807727766276792
GRACILE BONE DYSPLASIA; GCLEB	0.011831613000000001	0.7793539924227872
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.011746451	0.7737443308573937
OROFACIODIGITAL SYNDROME I; OFD1	0.011746451	0.7737443308573937
POTOCKI-SHAFFER SYNDROME	0.011746451	0.7737443308573937
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.01168895	0.7699567125573105
HAND-FOOT-GENITAL SYNDROME; HFG	0.01168895	0.7699567125573105
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.01168895	0.7699567125573105
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01168895	0.7699567125573105
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01168895	0.7699567125573105
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.01168895	0.7699567125573105
WEYERS ACROFACIAL DYSOSTOSIS	0.01168895	0.7699567125573105
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.01168895	0.7699567125573105
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.01168895	0.7699567125573105
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01168895	0.7699567125573105
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.011674582000000001	0.7690102855432482
#614976 CARPENTER SYNDROME 2; CRPT2	0.011674582000000001	0.7690102855432482
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.011674582000000001	0.7690102855432482
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.011530963000000002	0.7595500335017247
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.011530963	0.7595500335017245
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.011530963	0.7595500335017245
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.011530963	0.7595500335017245
BOHRING-OPITZ SYNDROME	0.011530963	0.7595500335017245
HEART AND BRAIN MALFORMATION SYNDROME	0.011530963	0.7595500335017245
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.011468373	0.7554272003440019
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.011468373	0.7554272003440019
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.011468373	0.7554272003440019
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.011468373	0.7554272003440019
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011468373	0.7554272003440019
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.011468373	0.7554272003440019
SCHINDLER DISEASE, TYPE I	0.011468373	0.7554272003440019
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.011468373	0.7554272003440019
AICARDI-GOUTIERES SYNDROME 7	0.011468373	0.7554272003440019
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.011468373	0.7554272003440019
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.011468373	0.7554272003440019
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.011468373	0.7554272003440019
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.011468373	0.7554272003440019
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.011468373	0.7554272003440019
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.011468373	0.7554272003440019
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.011468373	0.7554272003440019
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.011468373	0.7554272003440019
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.011468373	0.7554272003440019
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.011468373	0.7554272003440019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011468373	0.7554272003440019
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.011468373	0.7554272003440019
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011468373	0.7554272003440019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.011468373	0.7554272003440019
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.011468373	0.7554272003440019
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.011468373	0.7554272003440019
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011468373	0.7554272003440019
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.011468373	0.7554272003440019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.011468373	0.7554272003440019
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.011468373	0.7554272003440019
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.011468373	0.7554272003440019
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.011468373	0.7554272003440019
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011468373	0.7554272003440019
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.011468373	0.7554272003440019
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0113883	0.7501527536362479
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0113883	0.7501527536362479
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.011151933000000001	0.7345831465905309
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.011151933000000001	0.7345831465905309
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01100927	0.7251858667250541
WILLIAMS-BEUREN SYNDROME; WBS	0.01100927	0.7251858667250541
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.01100927	0.7251858667250541
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.010915862	0.7190330372060166
COFFIN-SIRIS SYNDROME 7; CSS7	0.010915862	0.7190330372060166
CRANIOECTODERMAL DYSPLASIA 1	0.0108307	0.7134233756406232
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0108307	0.7134233756406232
FRONTONASAL DYSPLASIA 1; FND1	0.0108307	0.7134233756406232
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.010687081000000001	0.7039631235990996
KRABBE DISEASE	0.010624491	0.6998402904413769
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.010624491	0.6998402904413769
ALEXANDER DISEASE	0.010624491	0.6998402904413769
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.010624491	0.6998402904413769
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.010624491	0.6998402904413769
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.010624491	0.6998402904413769
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.010624491	0.6998402904413769
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.010624491	0.6998402904413769
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.010624491	0.6998402904413769
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.010624491	0.6998402904413769
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.010624491	0.6998402904413769
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.010624491	0.6998402904413769
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.010624491	0.6998402904413769
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.010624491	0.6998402904413769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.010624491	0.6998402904413769
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.010624491	0.6998402904413769
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.010624491	0.6998402904413769
RETT SYNDROME, CONGENITAL VARIANT	0.010624491	0.6998402904413769
ASPARTYLGLUCOSAMINURIA; AGU	0.010624491	0.6998402904413769
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.010624491	0.6998402904413769
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.010624491	0.6998402904413769
RETT SYNDROME; RTT	0.010624491	0.6998402904413769
STEEL SYNDROME; STLS	0.010615212	0.6992290782849541
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.010615211999999999	0.699229078284954
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.010552622000000001	0.6951062451272315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.010552622000000001	0.6951062451272315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010552622000000001	0.6951062451272315
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010552622000000001	0.6951062451272315
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.010552622000000001	0.6951062451272315
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.010552622000000001	0.6951062451272315
AICARDI-GOUTIERES SYNDROME 6	0.010552622000000001	0.6951062451272315
HYPERMANGANESEMIA WITH DYSTONIA 2	0.010552622000000001	0.6951062451272315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.010308051	0.6789962366879059
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.010308051	0.6789962366879059
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.010308051	0.6789962366879059
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010308051	0.6789962366879059
JOUBERT SYNDROME 1	0.010236182	0.6742621913737603
NOONAN SYNDROME 5; NS5	0.010236182	0.6742621913737603
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.010236182	0.6742621913737603
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.010236182	0.6742621913737603
KEIPERT SYNDROME; KPTS	0.010071980000000001	0.6634461273033918
ODONTOCHONDRODYSPLASIA; ODCD	0.010071980000000001	0.6634461273033918
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.010071980000000001	0.6634461273033918
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.010071980000000001	0.6634461273033918
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00977133	0.643642168382329
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00977133	0.643642168382329
HYPERTELORISM, TEEBI TYPE; TBHS	0.00977133	0.643642168382329
SHORT SYNDROME	0.00977133	0.643642168382329
TEEBI-SHALTOUT SYNDROME; TBSH	0.00977133	0.643642168382329
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00977133	0.643642168382329
ZECHI-CEIDE SYNDROME	0.00977133	0.643642168382329
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00970874	0.6395193352246065
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00970874	0.6395193352246065
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00970874	0.6395193352246065
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00970874	0.6395193352246065
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00970874	0.6395193352246065
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00970874	0.6395193352246065
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.6395193352246065
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00970874	0.6395193352246065
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00970874	0.6395193352246065
Glycosylphosphatidylinositol biosynthesis defect 18	0.009511573	0.6265318508787252
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.009511573	0.6265318508787252
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009511573	0.6265318508787252
RECOMBINANT CHROMOSOME 8 SYNDROME	0.009511573	0.6265318508787252
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009511573	0.6265318508787252
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.009511573	0.6265318508787252
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.009511573	0.6265318508787252
CHROMOSOME 16p13.2 DELETION SYNDROME	0.009511573	0.6265318508787252
CHROMOSOME 16p13.3 DELETION SYNDROME	0.009511573	0.6265318508787252
CATEL-MANZKE SYNDROME; CATMANS	0.009511573	0.6265318508787252
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.009511573	0.6265318508787252
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.009511573	0.6265318508787252
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0093923	0.6186752814711353
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0093923	0.6186752814711353
CEREBROOCULONASAL SYNDROME	0.0093923	0.6186752814711353
NASODIGITOACOUSTIC SYNDROME	0.0093923	0.6186752814711353
SMITH-MAGENIS SYNDROME; SMS	0.009333003	0.6147693597942943
#300867 KABUKI SYNDROME 2; KABUK2	0.008953973	0.5898024728831007
BRANCHIOOCULOFACIAL SYNDROME	0.008667691	0.5709449409761003
CORNELIA DE LANGE SYNDROME 1	0.008667691	0.5709449409761003
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.008667691	0.5709449409761003
SECKEL SYNDROME 1; SCKL1	0.008667691	0.5709449409761003
WARBURG MICRO SYNDROME 3; WARBM3	0.008667691	0.5709449409761003
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.008653323000000001	0.569998513962038
CHROMOSOME 10Q26 DELETION SYNDROME	0.008653323000000001	0.569998513962038
C SYNDROME	0.008653323000000001	0.569998513962038
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.008653323000000001	0.569998513962038
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008653323000000001	0.569998513962038
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.008653323000000001	0.569998513962038
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.008653323000000001	0.569998513962038
BARAITSER-WINTER SYNDROME 1; BRWS1	0.008653323000000001	0.569998513962038
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.008653323000000001	0.569998513962038
OCULOECTODERMAL SYNDROME; OES	0.008653323000000001	0.569998513962038
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.008653323000000001	0.569998513962038
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.008653323000000001	0.569998513962038
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.008595822	0.5662108956619547
POPOV-CHANG SYNDROME; POPCHAS	0.008595822	0.5662108956619547
CHAR SYNDROME	0.008595822	0.5662108956619547
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.008595822	0.5662108956619547
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008595822	0.5662108956619547
SILVER-RUSSELL SYNDROME; SRS	0.008595822	0.5662108956619547
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.008595822	0.5662108956619547
AYME-GRIPP SYNDROME; AYGRP	0.008489121	0.5591824498916694
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.008489121	0.5591824498916694
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.008417252	0.5544484045775239
Aarskog-Scott syndrome	0.008417252	0.5544484045775239
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.008417252	0.5544484045775239
ELSAHY-WATERS SYNDROME; ESWS	0.008417252	0.5544484045775239
TONNE-KALSCHEUER SYNDROME; TOKAS	0.008417252	0.5544484045775239
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.008417252	0.5544484045775239
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.008417252	0.5544484045775239
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.008110091	0.5342155629804757
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.008110091	0.5342155629804757
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.008038222000000001	0.5294815176663301
BARATELA-SCOTT SYNDROME	0.008038222000000001	0.5294815176663301
OROFACIODIGITAL SYNDROME VI	0.008038222000000001	0.5294815176663301
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007894603	0.5200212656248064
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.007894603	0.5200212656248064
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.007894603	0.5200212656248064
WEBB-DATTANI SYNDROME; WEDAS	0.007894603	0.5200212656248064
PETTIGREW SYNDROME	0.007894603	0.5200212656248064
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.007894603	0.5200212656248064
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007894603	0.5200212656248064
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007894603	0.5200212656248064
DESANTO-SHINAWI SYNDROME	0.007894603	0.5200212656248064
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.007894603	0.5200212656248064
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.007894603	0.5200212656248064
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.007894603	0.5200212656248064
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.007894603	0.5200212656248064
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.007809441	0.514411604059413
LATHOSTEROLOSIS	0.007809441	0.514411604059413
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.007809441	0.514411604059413
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.007809441	0.514411604059413
WT LIMB-BLOOD SYNDROME	0.00775194	0.5106239857593297
MOLAR I REINCLUSION	0.00775194	0.5106239857593297
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00775194	0.5106239857593297
FIBROCHONDROGENESIS 1; FBCG1	0.00775194	0.5106239857593297
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00775194	0.5106239857593297
NAIL-PATELLA SYNDROME	0.00775194	0.5106239857593297
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00775194	0.5106239857593297
BRACHYDACTYLY, TYPE A2; BDA2	0.00775194	0.5106239857593297
MEIER-GORLIN SYNDROME 1; MGORS1	0.00775194	0.5106239857593297
SECKEL SYNDROME 5; SCKL5	0.00775194	0.5106239857593297
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00775194	0.5106239857593297
JOHANSON-BLIZZARD SYNDROME; JBS	0.00775194	0.5106239857593297
MICROCEPHALY-CARDIOMYOPATHY	0.00775194	0.5106239857593297
SECKEL SYNDROME 2; SCKL2	0.00775194	0.5106239857593297
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00775194	0.5106239857593297
BLOOM SYNDROME	0.00775194	0.5106239857593297
BRACHYDACTYLY, TYPE A3	0.00775194	0.5106239857593297
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00775194	0.5106239857593297
TETRALOGY OF FALLOT	0.00775194	0.5106239857593297
PELVIS-SHOULDER DYSPLASIA	0.00775194	0.5106239857593297
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00775194	0.5106239857593297
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00775194	0.5106239857593297
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00775194	0.5106239857593297
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00775194	0.5106239857593297
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00775194	0.5106239857593297
TALONAVICULAR COALITION	0.00775194	0.5106239857593297
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00775194	0.5106239857593297
HUNTER-MACDONALD SYNDROME	0.00775194	0.5106239857593297
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00775194	0.5106239857593297
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.00775194	0.5106239857593297
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00775194	0.5106239857593297
FLOATING-HARBOR SYNDROME	0.00775194	0.5106239857593297
3MC SYNDROME 1	0.00775194	0.5106239857593297
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.00775194	0.5106239857593297
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.5106239857593297
BOWEN-CONRADI SYNDROME	0.00775194	0.5106239857593297
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00775194	0.5106239857593297
BRACHYDACTYLY, TYPE A1, D	0.00775194	0.5106239857593297
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00775194	0.5106239857593297
SYNPOLYDACTYLY 1	0.00775194	0.5106239857593297
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00775194	0.5106239857593297
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00775194	0.5106239857593297
CLEIDORHIZOMELIC SYNDROME	0.00775194	0.5106239857593297
OCULOSKELETODENTAL SYNDROME; OCSKD	0.007737572	0.5096775587452674
CHROMOSOME 9P DELETION SYNDROME	0.007737572	0.5096775587452674
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.007737572	0.5096775587452674
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.007737572	0.5096775587452674
LAMB-SHAFFER SYNDROME	0.007737572	0.5096775587452674
COHEN-GIBSON SYNDROME; COGIS	0.007737572	0.5096775587452674
CHROMOSOME 16Q22 DELETION SYNDROME	0.007737572	0.5096775587452674
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.007737572	0.5096775587452674
NOONAN SYNDROME 6; NS6	0.007737572	0.5096775587452674
JOUBERT SYNDROME 10	0.007737572	0.5096775587452674
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00757337	0.4988614946748989
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00757337	0.4988614946748989
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00757337	0.4988614946748989
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00757337	0.4988614946748989
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00757337	0.4988614946748989
608028 THAI SYMPHALANGISM SYNDROME	0.00757337	0.4988614946748989
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00757337	0.4988614946748989
ROBERTS SYNDROME; RBS	0.00757337	0.4988614946748989
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00757337	0.4988614946748989
BASAL CELL NEVUS SYNDROME	0.00757337	0.4988614946748989
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00757337	0.4988614946748989
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00757337	0.4988614946748989
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00757337	0.4988614946748989
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00757337	0.4988614946748989
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0071943400000000005	0.4738946077637051
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0071943400000000005	0.4738946077637051
MOEBIUS SYNDROME; MBS	0.0071943400000000005	0.4738946077637051
OROFACIODIGITAL SYNDROME IV; OFD4	0.0071943400000000005	0.4738946077637051
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0071943400000000005	0.4738946077637051
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.0071943400000000005	0.4738946077637051
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0071943400000000005	0.4738946077637051
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0071943400000000005	0.4738946077637051
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0071943400000000005	0.4738946077637051
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0071943400000000005	0.4738946077637051
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0071943400000000005	0.4738946077637051
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.007050721	0.46443435572218145
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.007050721	0.46443435572218145
CLARK-BARAITSER SYNDROME	0.007050721	0.46443435572218145
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.007050721	0.46443435572218145
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.007050721	0.46443435572218145
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.007050721	0.46443435572218145
NOONAN SYNDROME 7; NS7	0.007050721	0.46443435572218145
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.007050721	0.46443435572218145
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.007050721	0.46443435572218145
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.007050721	0.46443435572218145
ATKIN-FLAITZ SYNDROME	0.007050721	0.46443435572218145
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.006978852	0.45970031040803594
MENTAL RETARDATION, X-LINKED 99	0.006978852	0.45970031040803594
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.006978852	0.45970031040803594
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.006978852	0.45970031040803594
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006978852	0.45970031040803594
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.006978852	0.45970031040803594
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.006978852	0.45970031040803594
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.006978852	0.45970031040803594
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006978852	0.45970031040803594
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.006978852	0.45970031040803594
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.006978852	0.45970031040803594
SAUL-WILSON SYNDROME; SWILS	0.006978852	0.45970031040803594
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.006978852	0.45970031040803594
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006978852	0.45970031040803594
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.006978852	0.45970031040803594
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.006978852	0.45970031040803594
#170100 PROLIDASE DEFICIENCY	0.006978852	0.45970031040803594
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.006978852	0.45970031040803594
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.006978852	0.45970031040803594
OMODYSPLASIA 1; OMOD1	0.00689369	0.4540906488426425
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00689369	0.4540906488426425
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00689369	0.4540906488426425
CRI-DU-CHAT SYNDROME	0.00689369	0.4540906488426425
#278250 WRINKLY SKIN SYNDROME; WSS	0.00689369	0.4540906488426425
SHPRINTZEN OMPHALOCELE SYNDROME	0.00689369	0.4540906488426425
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00689369	0.4540906488426425
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00689369	0.4540906488426425
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00689369	0.4540906488426425
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00689369	0.4540906488426425
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00689369	0.4540906488426425
SCARF SYNDROME	0.00689369	0.4540906488426425
JOUBERT SYNDROME 3; JBTS3	0.00689369	0.4540906488426425
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00689369	0.4540906488426425
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00689369	0.4540906488426425
600736 VELOFACIOSKELETAL SYNDROME	0.00689369	0.4540906488426425
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00689369	0.4540906488426425
FEINGOLD SYNDROME 1; FGLDS1	0.00689369	0.4540906488426425
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00689369	0.4540906488426425
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00613497	0.4041134005054109
MARSHALL-SMITH SYNDROME; MRSHSS	0.00613497	0.4041134005054109
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00613497	0.4041134005054109
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00613497	0.4041134005054109
OSTEOGENESIS IMPERFECTA, TYPE X	0.00613497	0.4041134005054109
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00613497	0.4041134005054109
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00613497	0.4041134005054109
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00613497	0.4041134005054109
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.00613497	0.4041134005054109
MENTAL RETARDATION, X-LINKED 93	0.00613497	0.4041134005054109
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00613497	0.4041134005054109
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00613497	0.4041134005054109
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00613497	0.4041134005054109
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00613497	0.4041134005054109
MENTAL RETARDATION, X-LINKED 19	0.00613497	0.4041134005054109
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00613497	0.4041134005054109
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00613497	0.4041134005054109
FG SYNDROME 2; FGS2	0.00613497	0.4041134005054109
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00613497	0.4041134005054109
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00613497	0.4041134005054109
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.00613497	0.4041134005054109
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00613497	0.4041134005054109
TRICHOHEPATOENTERIC SYNDROME 1	0.00613497	0.4041134005054109
TRICHOHEPATOENTERIC SYNDROME 2	0.00613497	0.4041134005054109
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.00613497	0.4041134005054109
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00613497	0.4041134005054109
#150250 LARSEN SYNDROME; LRS	0.00613497	0.4041134005054109
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00613497	0.4041134005054109
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00613497	0.4041134005054109
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00613497	0.4041134005054109
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00613497	0.4041134005054109
268650 RUDIGER SYNDROME	0.00613497	0.4041134005054109
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00613497	0.4041134005054109
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00613497	0.4041134005054109
TEMTAMY SYNDROME; TEMTYS	0.005696643	0.37524059191737624
COFFIN-SIRIS SYNDROME 2; CSS2	0.005696643	0.37524059191737624
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.005696643	0.37524059191737624
SCHAAF-YANG SYNDROME; SHFYNG	0.005696643	0.37524059191737624
ADAMS-OLIVER SYNDROME 1; AOS1	0.005696643	0.37524059191737624
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.005696643	0.37524059191737624
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.005696643	0.37524059191737624
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.005696643	0.37524059191737624
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.005696643	0.37524059191737624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.005395993	0.35543663299631356
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005395993	0.35543663299631356
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.005395993	0.35543663299631356
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.005395993	0.35543663299631356
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.005395993	0.35543663299631356
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.005395993	0.35543663299631356
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005395993	0.35543663299631356
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005395993	0.35543663299631356
KABUKI SYNDROME 1	0.005395993	0.35543663299631356
CHROMOSOME 1p35 DELETION SYNDROME	0.005395993	0.35543663299631356
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.005395993	0.35543663299631356
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.005395993	0.35543663299631356
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005395993	0.35543663299631356
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005395993	0.35543663299631356
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.005395993	0.35543663299631356
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.005395993	0.35543663299631356
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.005395993	0.35543663299631356
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.005395993	0.35543663299631356
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005395993	0.35543663299631356
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005395993	0.35543663299631356
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.005395993	0.35543663299631356
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.005395993	0.35543663299631356
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005016963	0.33046974608511986
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005016963	0.33046974608511986
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005016963	0.33046974608511986
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.005016963	0.33046974608511986
PEHO SYNDROME; PEHO	0.005016963	0.33046974608511986
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.005016963	0.33046974608511986
MENTAL RETARDATION, X-LINKED 91; MRX91	0.005016963	0.33046974608511986
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005016963	0.33046974608511986
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005016963	0.33046974608511986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005016963	0.33046974608511986
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.005016963	0.33046974608511986
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.005016963	0.33046974608511986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005016963	0.33046974608511986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.005016963	0.33046974608511986
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005016963	0.33046974608511986
XQ25 DUPLICATION SYNDROME	0.005016963	0.33046974608511986
WEAVER SYNDROME	0.005016963	0.33046974608511986
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.005016963	0.33046974608511986
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.005016963	0.33046974608511986
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.005016963	0.33046974608511986
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005016963	0.33046974608511986
TEMPLE-BARAITSER SYNDROME; TMBTS	0.005016963	0.33046974608511986
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.005016963	0.33046974608511986
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.005016963	0.33046974608511986
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.005016963	0.33046974608511986
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005016963	0.33046974608511986
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004852761000000001	0.3196536820147513
Myhre syndrome	0.004852761000000001	0.3196536820147513
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004852761000000001	0.3196536820147513
CRANIOSYNOSTOSIS 2	0.004852761000000001	0.3196536820147513
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.004852761000000001	0.3196536820147513
KLEEFSTRA SYNDROME	0.004852761000000001	0.3196536820147513
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004852761000000001	0.3196536820147513
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.004852761000000001	0.3196536820147513
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.004852761000000001	0.3196536820147513
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004852761000000001	0.3196536820147513
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004852761000000001	0.3196536820147513
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.004852761000000001	0.3196536820147513
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.004852761000000001	0.3196536820147513
ADAMS-OLIVER SYNDROME 5; AOS5	0.004852761000000001	0.3196536820147513
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.004852761000000001	0.3196536820147513
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.004780892	0.31491963670060574
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.004780892	0.31491963670060574
BARDET-BIEDL SYNDROME 3; BBS3	0.004780892	0.31491963670060574
CHOPS SYNDROME; CHOPS	0.004780892	0.31491963670060574
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.004780892	0.31491963670060574
BARDET-BIEDL SYNDROME 1; BBS1	0.004780892	0.31491963670060574
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.004780892	0.31491963670060574
BARDET-BIEDL SYNDROME 17; BBS17	0.004780892	0.31491963670060574
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.004780892	0.31491963670060574
AL-RAQAD SYNDROME; ARS	0.004780892	0.31491963670060574
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.004780892	0.31491963670060574
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.004780892	0.31491963670060574
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.004780892	0.31491963670060574
GENITOPATELLAR SYNDROME; GTPTS	0.004780892	0.31491963670060574
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.004780892	0.31491963670060574
FILIPPI SYNDROME; FLPIS	0.004552111	0.2998497230936886
GLUTAMINE DEFICIENCY, CONGENITAL	0.004552111	0.2998497230936886
LISSENCEPHALY, X-LINKED, 2	0.004552111	0.2998497230936886
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.004552111	0.2998497230936886
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.004552111	0.2998497230936886
311450 PALLISTER W SYNDROME;;W SYNDROME	0.004552111	0.2998497230936886
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.004552111	0.2998497230936886
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.004552111	0.2998497230936886
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004552111	0.2998497230936886
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004552111	0.2998497230936886
PITT-HOPKINS SYNDROME	0.004552111	0.2998497230936886
ZIMMERMANN-LABAND SYNDROME 1	0.004552111	0.2998497230936886
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.004552111	0.2998497230936886
FRYNS SYNDROME; FRNS	0.004552111	0.2998497230936886
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004552111	0.2998497230936886
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004552111	0.2998497230936886
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.004480242	0.29511567777954306
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004480242	0.29511567777954306
GOLDBERG-SHPRINTZEN SYNDROME	0.004480242	0.29511567777954306
TARP SYNDROME; TARPS	0.004480242	0.29511567777954306
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004480242	0.29511567777954306
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.004480242	0.29511567777954306
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.004480242	0.29511567777954306
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004480242	0.29511567777954306
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.004480242	0.29511567777954306
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.004480242	0.29511567777954306
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.004480242	0.29511567777954306
CHROMOSOME 18P DELETION SYNDROME	0.004480242	0.29511567777954306
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.004480242	0.29511567777954306
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.004480242	0.29511567777954306
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.004480242	0.29511567777954306
ALAZAMI SYNDROME; ALAZS	0.004480242	0.29511567777954306
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004480242	0.29511567777954306
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.004480242	0.29511567777954306
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.004480242	0.29511567777954306
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.004480242	0.29511567777954306
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.004480242	0.29511567777954306
SWEENEY-COX SYNDROME; SWCOS	0.004480242	0.29511567777954306
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004173081	0.2748828361824949
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.004173081	0.2748828361824949
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.004173081	0.2748828361824949
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.004173081	0.2748828361824949
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.004173081	0.2748828361824949
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.004173081	0.2748828361824949
MARDEN-WALKER SYNDROME	0.004173081	0.2748828361824949
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004173081	0.2748828361824949
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.004173081	0.2748828361824949
MECKEL SYNDROME, TYPE 10; MKS10	0.004173081	0.2748828361824949
OCULODENTODIGITAL DYSPLASIA; ODDD	0.004173081	0.2748828361824949
CHROMOSOME 18Q DELETION SYNDROME	0.004173081	0.2748828361824949
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.004101212	0.27014879086834936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004101212	0.27014879086834936
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.004101212	0.27014879086834936
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.004101212	0.27014879086834936
JOUBERT SYNDROME 14	0.004101212	0.27014879086834936
HARTSFIELD SYNDROME; HRTFDS	0.004101212	0.27014879086834936
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004101212	0.27014879086834936
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004101212	0.27014879086834936
WARSAW BREAKAGE SYNDROME; WABS	0.004101212	0.27014879086834936
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004101212	0.27014879086834936
FRONTOOCULAR SYNDROME	0.004101212	0.27014879086834936
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.004101212	0.27014879086834936
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.004101212	0.27014879086834936
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004101212	0.27014879086834936
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.004101212	0.27014879086834936
THAUVIN-ROBINET-FAIVRE SYNDROME	0.004101212	0.27014879086834936
Mental retardation, autosomal dominant 21	0.004101212	0.27014879086834936
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004101212	0.27014879086834936
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004101212	0.27014879086834936
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004101212	0.27014879086834936
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.004101212	0.27014879086834936
HADZISELIMOVIC SYNDROME	0.004101212	0.27014879086834936
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004101212	0.27014879086834936
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004101212	0.27014879086834936
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.004101212	0.27014879086834936
DESBUQUOIS DYSPLASIA 2; DBQD2	0.004101212	0.27014879086834936
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.004101212	0.27014879086834936
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.004101212	0.27014879086834936
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004101212	0.27014879086834936
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004101212	0.27014879086834936
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.004101212	0.27014879086834936
LYMPHEDEMA, HEREDITARY, III	0.004101212	0.27014879086834936
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004101212	0.27014879086834936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004101212	0.27014879086834936
NOONAN SYNDROME 3; NS3	0.004101212	0.27014879086834936
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.004101212	0.27014879086834936
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004101212	0.27014879086834936
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00393701	0.25933272679798075
EIKEN SYNDROME	0.00393701	0.25933272679798075
FEINGOLD SYNDROME 2; FGLDS2	0.00393701	0.25933272679798075
MAL DE MELEDA	0.00393701	0.25933272679798075
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00393701	0.25933272679798075
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00393701	0.25933272679798075
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00393701	0.25933272679798075
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00393701	0.25933272679798075
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00393701	0.25933272679798075
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00393701	0.25933272679798075
BARDET-BIEDL SYNDROME 18; BBS18	0.00393701	0.25933272679798075
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00393701	0.25933272679798075
CHITAYAT SYNDROME	0.00393701	0.25933272679798075
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.00393701	0.25933272679798075
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00393701	0.25933272679798075
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00393701	0.25933272679798075
GRANGE SYNDROME; GRNG	0.00393701	0.25933272679798075
Smith-Magenis Syndrome	0.00393701	0.25933272679798075
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00393701	0.25933272679798075
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00393701	0.25933272679798075
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00393701	0.25933272679798075
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00393701	0.25933272679798075
SATOYOSHI SYNDROME	0.00393701	0.25933272679798075
SYMPHALANGISM, DISTAL	0.00393701	0.25933272679798075
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00393701	0.25933272679798075
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00393701	0.25933272679798075
#100800 ACHONDROPLASIA; ACH	0.00393701	0.25933272679798075
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00393701	0.25933272679798075
THANATOPHORIC DYSPLASIA, TYPE II	0.00393701	0.25933272679798075
SYNDACTYLY, TYPE V	0.00393701	0.25933272679798075
HYPOCHONDROPLASIA	0.00393701	0.25933272679798075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00393701	0.25933272679798075
RHYNS SYNDROME; RHYNS	0.00393701	0.25933272679798075
BRACHYDACTYLY, LONG-THUMB TYPE	0.00393701	0.25933272679798075
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00393701	0.25933272679798075
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00393701	0.25933272679798075
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00393701	0.25933272679798075
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00393701	0.25933272679798075
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00393701	0.25933272679798075
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00393701	0.25933272679798075
SCHNECKENBECKEN DYSPLASIA	0.00393701	0.25933272679798075
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00393701	0.25933272679798075
CAMPTOBRACHYDACTYLY	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00393701	0.25933272679798075
FOCAL DERMAL HYPOPLASIA; FDH	0.00393701	0.25933272679798075
CRANIOECTODERMAL DYSPLASIA 3	0.00393701	0.25933272679798075
DESBUQUOIS DYSPLASIA 1	0.00393701	0.25933272679798075
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00393701	0.25933272679798075
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00393701	0.25933272679798075
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00393701	0.25933272679798075
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00393701	0.25933272679798075
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00393701	0.25933272679798075
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00393701	0.25933272679798075
MULTIPLE SYNOSTOSES SYNDROME 2	0.00393701	0.25933272679798075
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00393701	0.25933272679798075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.25933272679798075
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00393701	0.25933272679798075
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00393701	0.25933272679798075
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00393701	0.25933272679798075
WEILL-MARCHESANI SYNDROME 3	0.00393701	0.25933272679798075
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00393701	0.25933272679798075
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00393701	0.25933272679798075
#612576 CHROMOSOME 17P13.3, TELOMERIC, DUPLICATION SYNDROME;;SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	0.00393701	0.25933272679798075
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00393701	0.25933272679798075
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00393701	0.25933272679798075
BRACHYDACTYLY, TYPE E	0.00393701	0.25933272679798075
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00393701	0.25933272679798075
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00393701	0.25933272679798075
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00393701	0.25933272679798075
2q37 monosomy	0.00393701	0.25933272679798075
MACS SYNDROME	0.00393701	0.25933272679798075
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00393701	0.25933272679798075
BARDET-BIEDL SYNDROME 4; BBS4	0.00393701	0.25933272679798075
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00393701	0.25933272679798075
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00393701	0.25933272679798075
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00393701	0.25933272679798075
BARDET-BIEDL SYNDROME 5; BBS5	0.00393701	0.25933272679798075
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.00393701	0.25933272679798075
METATROPIC DYSPLASIA	0.00393701	0.25933272679798075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00393701	0.25933272679798075
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00393701	0.25933272679798075
SPONDYLOPERIPHERAL DYSPLASIA	0.00393701	0.25933272679798075
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00393701	0.25933272679798075
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00393701	0.25933272679798075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00393701	0.25933272679798075
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00393701	0.25933272679798075
BRACHYDACTYLY, TYPE E2; BDE2	0.00393701	0.25933272679798075
ANAUXETIC DYSPLASIA 2; ANXD2	0.00393701	0.25933272679798075
PYCNODYSOSTOSIS	0.00393701	0.25933272679798075
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00393701	0.25933272679798075
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.00393701	0.25933272679798075
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00393701	0.25933272679798075
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00393701	0.25933272679798075
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00393701	0.25933272679798075
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00393701	0.25933272679798075
CLEIDOCRANIAL DYSPLASIA; CCD	0.00393701	0.25933272679798075
PSEUDOACHONDROPLASIA	0.00393701	0.25933272679798075
ADAMS-OLIVER SYNDROME 6; AOS6	0.00393701	0.25933272679798075
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00363636	0.2395287678769181
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00363636	0.2395287678769181
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00363636	0.2395287678769181
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00363636	0.2395287678769181
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00363636	0.2395287678769181
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00363636	0.2395287678769181
DIAMOND-BLACKFAN ANEMIA 8	0.00363636	0.2395287678769181
STROMME SYNDROME; STROMS	0.00363636	0.2395287678769181
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00363636	0.2395287678769181
FRONTONASAL DYSPLASIA 2; FND2	0.00363636	0.2395287678769181
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00363636	0.2395287678769181
MICROPHTHALMIA, SYNDROMIC 12	0.00363636	0.2395287678769181
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00363636	0.2395287678769181
OROFACIODIGITAL SYNDROME XV; OFD15	0.00363636	0.2395287678769181
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00363636	0.2395287678769181
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00363636	0.2395287678769181
DEAFNESS-CRANIOFACIAL SYNDROME	0.00363636	0.2395287678769181
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00363636	0.2395287678769181
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.00363636	0.2395287678769181
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.00363636	0.2395287678769181
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00363636	0.2395287678769181
DEAFNESS, X-LINKED 7; DFNX7	0.00363636	0.2395287678769181
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00363636	0.2395287678769181
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00363636	0.2395287678769181
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00363636	0.2395287678769181
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00363636	0.2395287678769181
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00363636	0.2395287678769181
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00363636	0.2395287678769181
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00363636	0.2395287678769181
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00363636	0.2395287678769181
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00363636	0.2395287678769181
BOOMERANG DYSPLASIA	0.00363636	0.2395287678769181
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00363636	0.2395287678769181
SCLEROSTEOSIS 1; SOST1	0.00363636	0.2395287678769181
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00363636	0.2395287678769181
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.00363636	0.2395287678769181
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00363636	0.2395287678769181
FRONTOMETAPHYSEAL DYSPLASIA	0.00363636	0.2395287678769181
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00363636	0.2395287678769181
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00363636	0.2395287678769181
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00363636	0.2395287678769181
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00363636	0.2395287678769181
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00363636	0.2395287678769181
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00363636	0.2395287678769181
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00363636	0.2395287678769181
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00363636	0.2395287678769181
TRISOMY 18-LIKE SYNDROME	0.00363636	0.2395287678769181
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00363636	0.2395287678769181
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00363636	0.2395287678769181
SIMOSA CRANIOFACIAL SYNDROME	0.00363636	0.2395287678769181
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00363636	0.2395287678769181
Mulchandani-Bhoj-Conlin syndrome	0.00325733	0.21456188096572443
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00325733	0.21456188096572443
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00325733	0.21456188096572443
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00325733	0.21456188096572443
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00325733	0.21456188096572443
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.21456188096572443
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00325733	0.21456188096572443
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00325733	0.21456188096572443
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00325733	0.21456188096572443
EHLERS-DANLOS SYNDROME, TYPE VI	0.00325733	0.21456188096572443
SCHOLTE SYNDROME; SHLTS	0.00325733	0.21456188096572443
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00325733	0.21456188096572443
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00325733	0.21456188096572443
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00325733	0.21456188096572443
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00325733	0.21456188096572443
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00325733	0.21456188096572443
COFFIN-SIRIS SYNDROME 10; CSS10	0.00325733	0.21456188096572443
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00325733	0.21456188096572443
MARTSOLF SYNDROME	0.00325733	0.21456188096572443
DUANE-RADIAL RAY SYNDROME; DRRS	0.00325733	0.21456188096572443
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00325733	0.21456188096572443
BRITTLE CORNEA SYNDROME	0.00325733	0.21456188096572443
CHROMOSOME 13q14 DELETION SYNDROME	0.00325733	0.21456188096572443
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00325733	0.21456188096572443
PTERYGIUM COLLI, ISOLATED	0.00325733	0.21456188096572443
#154780 MARSHALL SYNDROME; MRSHS	0.00325733	0.21456188096572443
HYPOGLOSSIA-HYPODACTYLIA	0.00325733	0.21456188096572443
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00325733	0.21456188096572443
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00325733	0.21456188096572443
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00325733	0.21456188096572443
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00325733	0.21456188096572443
LICHTENSTEIN SYNDROME	0.00325733	0.21456188096572443
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00325733	0.21456188096572443
EPICANTHUS	0.00325733	0.21456188096572443
#611554 LEOPARD SYNDROME 2	0.00325733	0.21456188096572443
LEGIUS SYNDROME	0.00325733	0.21456188096572443
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00325733	0.21456188096572443
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00325733	0.21456188096572443
PFEIFFER-PALM-TELLER SYNDROME	0.00325733	0.21456188096572443
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00325733	0.21456188096572443
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00325733	0.21456188096572443
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00325733	0.21456188096572443
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00325733	0.21456188096572443
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00325733	0.21456188096572443
EHLERS-DANLOS SYNDROME, TYPE I	0.00325733	0.21456188096572443
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00325733	0.21456188096572443
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00325733	0.21456188096572443
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00325733	0.21456188096572443
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00325733	0.21456188096572443
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00325733	0.21456188096572443
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00325733	0.21456188096572443
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00325733	0.21456188096572443
SIFRIM-HITZ-WEISS SYNDROME	0.00325733	0.21456188096572443
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00325733	0.21456188096572443
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00325733	0.21456188096572443
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00325733	0.21456188096572443
NOONAN SYNDROME 8; NS8	0.00325733	0.21456188096572443
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001759633	0.11590786511939549
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.11590786511939549
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11590786511939549
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11590786511939549
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.11590786511939549
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11590786511939549
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.11590786511939549
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001759633	0.11590786511939549
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.11590786511939549
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.11590786511939549
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001759633	0.11590786511939549
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.11590786511939549
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.11590786511939549
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.11590786511939549
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.11590786511939549
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.11590786511939549
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.11590786511939549
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.11590786511939549
Pontine tegmental cap dysplasia	0.001759633	0.11590786511939549
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.11590786511939549
PHACE ASSOCIATION	0.001759633	0.11590786511939549
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.11590786511939549
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.11590786511939549
COFFIN-SIRIS SYNDROME 4; CSS4	0.001759633	0.11590786511939549
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.11590786511939549
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.11590786511939549
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.001759633	0.11590786511939549
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.11590786511939549
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.11590786511939549
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.11590786511939549
SALLA DISEASE	0.001759633	0.11590786511939549
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001759633	0.11590786511939549
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.11590786511939549
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.11590786511939549
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.11590786511939549
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.11590786511939549
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.11590786511939549
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.11590786511939549
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.11590786511939549
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.11590786511939549
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.11590786511939549
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.11590786511939549
CODAS SYNDROME	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.11590786511939549
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.11590786511939549
KETOADIPICACIDURIA	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001759633	0.11590786511939549
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001759633	0.11590786511939549
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001759633	0.11590786511939549
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11590786511939549
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.11590786511939549
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001759633	0.11590786511939549
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.11590786511939549
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.11590786511939549
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001759633	0.11590786511939549
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.11590786511939549
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.11590786511939549
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.11590786511939549
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.11590786511939549
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001759633	0.11590786511939549
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.11590786511939549
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.11590786511939549
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.11590786511939549
KBG SYNDROME	0.001759633	0.11590786511939549
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.11590786511939549
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.11590786511939549
Cerebral creatine deficiency syndrome 2	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.11590786511939549
LISSENCEPHALY 1; LIS1	0.001759633	0.11590786511939549
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.11590786511939549
CITRULLINEMIA, CLASSIC	0.001759633	0.11590786511939549
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11590786511939549
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.11590786511939549
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.11590786511939549
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.11590786511939549
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001759633	0.11590786511939549
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.11590786511939549
TIMOTHY SYNDROME; TS	0.001759633	0.11590786511939549
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.11590786511939549
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11590786511939549
COFFIN-SIRIS SYNDROME 5	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11590786511939549
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.11590786511939549
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.11590786511939549
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001759633	0.11590786511939549
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.001759633	0.11590786511939549
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.11590786511939549
ADENYLOSUCCINASE DEFICIENCY	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.11590786511939549
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11590786511939549
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001759633	0.11590786511939549
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.11590786511939549
LISSENCEPHALY 8; LIS8	0.001759633	0.11590786511939549
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.11590786511939549
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.11590786511939549
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.11590786511939549
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.11590786511939549
GAUCHER DISEASE, TYPE II	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.11590786511939549
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.11590786511939549
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.11590786511939549
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.11590786511939549
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.11590786511939549
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001759633	0.11590786511939549
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.11590786511939549
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11590786511939549
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.11590786511939549
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11590786511939549
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.11590786511939549
MEHMO SYNDROME; MEHMO	0.001759633	0.11590786511939549
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.11590786511939549
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.11590786511939549
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.11590786511939549
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.11590786511939549
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.11590786511939549
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.11590786511939549
PROPIONIC ACIDEMIA	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.11590786511939549
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.11590786511939549
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.11590786511939549
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11590786511939549
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.11590786511939549
HOLOPROSENCEPHALY 7	0.001759633	0.11590786511939549
WAISMAN SYNDROME; WSMN	0.001759633	0.11590786511939549
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.11590786511939549
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.11590786511939549
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.11590786511939549
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.11590786511939549
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.11590786511939549
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001759633	0.11590786511939549
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.11590786511939549
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.11590786511939549
COFFIN-SIRIS SYNDROME 3; CSS3	0.001759633	0.11590786511939549
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001759633	0.11590786511939549
HARTNUP DISORDER	0.001759633	0.11590786511939549
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.11590786511939549
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.11590786511939549
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001759633	0.11590786511939549
GLASS SYNDROME	0.001759633	0.11590786511939549
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.11590786511939549
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.11590786511939549
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.11590786511939549
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.11590786511939549
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11590786511939549
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.11590786511939549
LANDAU-KLEFFNER SYNDROME	0.001759633	0.11590786511939549
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.11590786511939549
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001759633	0.11590786511939549
COACH SYNDROME	0.001759633	0.11590786511939549
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.11590786511939549
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.11590786511939549
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.11590786511939549
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.11590786511939549
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001759633	0.11590786511939549
SULFOCYSTEINURIA	0.001759633	0.11590786511939549
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001759633	0.11590786511939549
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.11590786511939549
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.11590786511939549
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.11590786511939549
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001759633	0.11590786511939549
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.11590786511939549
ANGELMAN SYNDROME	0.001759633	0.11590786511939549
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.11590786511939549
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.11590786511939549
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001759633	0.11590786511939549
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001759633	0.11590786511939549
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.11590786511939549
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.11590786511939549
Xq28 (MECP2) duplication	0.001759633	0.11590786511939549
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001759633	0.11590786511939549
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001759633	0.11590786511939549
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001759633	0.11590786511939549
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.11590786511939549
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001759633	0.11590786511939549
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.11590786511939549
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.11590786511939549
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.001759633	0.11590786511939549
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001759633	0.11590786511939549
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.11590786511939549
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.11590786511939549
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.11590786511939549
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001759633	0.11590786511939549
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.11590786511939549
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.11590786511939549
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.11590786511939549
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001759633	0.11590786511939549
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.11590786511939549
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.11590786511939549
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11590786511939549
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.11590786511939549
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.11590786511939549
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001759633	0.11590786511939549
LISSENCEPHALY 4	0.001759633	0.11590786511939549
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.11590786511939549
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.11590786511939549
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11590786511939549
DIGEORGE SYNDROME; DGS	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.11590786511939549
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.001759633	0.11590786511939549
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.11590786511939549
MEND SYNDROME; MEND	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.11590786511939549
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.11590786511939549
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.11590786511939549
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.11590786511939549
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.11590786511939549
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11590786511939549
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.11590786511939549
JABERI-ELAHI SYNDROME; JABELS	0.001759633	0.11590786511939549
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.001759633	0.11590786511939549
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.11590786511939549
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11590786511939549
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.11590786511939549
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.11590786511939549
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.11590786511939549
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.11590786511939549
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.11590786511939549
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.11590786511939549
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001759633	0.11590786511939549
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.11590786511939549
CHROMOSOME 19p13.13 DELETION SYNDROME	0.001759633	0.11590786511939549
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.11590786511939549
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001759633	0.11590786511939549
LEIGH SYNDROME; LS	0.001759633	0.11590786511939549
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11590786511939549
COFFIN-SIRIS SYNDROME 1; CSS1	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.11590786511939549
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.11590786511939549
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.11590786511939549
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.11590786511939549
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001759633	0.11590786511939549
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11590786511939549
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.11590786511939549
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.11590786511939549
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.11590786511939549
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.11590786511939549
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11590786511939549
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11590786511939549
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001759633	0.11590786511939549
ELEJALDE DISEASE	0.001759633	0.11590786511939549
PALLISTER-HALL SYNDROME	0.001759633	0.11590786511939549
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.11590786511939549
IMMUNODEFICIENCY 49; IMD49	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.11590786511939549
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.11590786511939549
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.11590786511939549
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.11590786511939549
VICI SYNDROME; VICIS	0.001759633	0.11590786511939549
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.11590786511939549
MIRAGE SYNDROME; MIRAGE	0.001759633	0.11590786511939549
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.11590786511939549
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.11590786511939549
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.11590786511939549
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.11590786511939549
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.11590786511939549
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.11590786511939549
MACDERMOT-WINTER SYNDROME	0.001759633	0.11590786511939549
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.11590786511939549
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.11590786511939549
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.11590786511939549
EMANUEL SYNDROME	0.001759633	0.11590786511939549
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.11590786511939549
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.11590786511939549
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.06032095521677051
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.06032095521677051
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.06032095521677051
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.06032095521677051
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.06032095521677051
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.06032095521677051
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.06032095521677051
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.06032095521677051
ALZHEIMER DISEASE 3; AD	0.000915751	0.06032095521677051
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.06032095521677051
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.06032095521677051
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.06032095521677051
EPILEPSY, READING	0.000915751	0.06032095521677051
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.06032095521677051
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.06032095521677051
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.06032095521677051
KAPUR-TORIELLO SYNDROME	0.000915751	0.06032095521677051
CROME SYNDROME	0.000915751	0.06032095521677051
LISSENCEPHALY 5; LIS5	0.000915751	0.06032095521677051
XYLOSIDASE DEFICIENCY	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.06032095521677051
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.06032095521677051
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.06032095521677051
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.06032095521677051
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000915751	0.06032095521677051
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.06032095521677051
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.06032095521677051
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.06032095521677051
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.06032095521677051
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.06032095521677051
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.06032095521677051
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.000915751	0.06032095521677051
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.06032095521677051
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.06032095521677051
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.06032095521677051
15q13.3 microdeletion syndrome	0.000915751	0.06032095521677051
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.06032095521677051
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.06032095521677051
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.06032095521677051
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.06032095521677051
LOWE OCULOCEREBRORENAL SYNDROME	0.000915751	0.06032095521677051
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000915751	0.06032095521677051
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.06032095521677051
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.06032095521677051
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.06032095521677051
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.06032095521677051
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.06032095521677051
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.06032095521677051
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.06032095521677051
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.06032095521677051
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.06032095521677051
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.06032095521677051
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.06032095521677051
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.000915751	0.06032095521677051
COCKAYNE SYNDROME A; CSA	0.000915751	0.06032095521677051
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.06032095521677051
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.06032095521677051
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.000915751	0.06032095521677051
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.06032095521677051
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.06032095521677051
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.06032095521677051
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.06032095521677051
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.06032095521677051
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.06032095521677051
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.06032095521677051
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.06032095521677051
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.06032095521677051
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.06032095521677051
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.06032095521677051
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000915751	0.06032095521677051
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.06032095521677051
GAUCHER DISEASE, TYPE IIIC	0.000915751	0.06032095521677051
PHENYLKETONURIA	0.000915751	0.06032095521677051
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.06032095521677051
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.06032095521677051
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.06032095521677051
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.06032095521677051
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.06032095521677051
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.06032095521677051
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.06032095521677051
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.06032095521677051
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.06032095521677051
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.06032095521677051
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.06032095521677051
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.06032095521677051
IMMUNODEFICIENCY 47	0.000915751	0.06032095521677051
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.06032095521677051
SMITH-KINGSMORE SYNDROME; SKS	0.000915751	0.06032095521677051
Adrenoleukodystrophy	0.000915751	0.06032095521677051
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.06032095521677051
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.06032095521677051
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.06032095521677051
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.06032095521677051
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.06032095521677051
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.06032095521677051
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.06032095521677051
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.06032095521677051
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000915751	0.06032095521677051
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.06032095521677051
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.06032095521677051
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.06032095521677051
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.06032095521677051
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.06032095521677051
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000915751	0.06032095521677051
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.06032095521677051
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.06032095521677051
GITELMAN SYNDROME	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.06032095521677051
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.06032095521677051
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.06032095521677051
COWDEN SYNDROME 6; CWS6	0.000915751	0.06032095521677051
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000915751	0.06032095521677051
PSEUDO-TORCH SYNDROME 2	0.000915751	0.06032095521677051
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.06032095521677051
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000915751	0.06032095521677051
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.06032095521677051
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.06032095521677051
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.06032095521677051
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000915751	0.06032095521677051
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.06032095521677051
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.06032095521677051
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.06032095521677051
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000915751	0.06032095521677051
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.06032095521677051
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.06032095521677051
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.06032095521677051
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.06032095521677051
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.06032095521677051
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.06032095521677051
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.06032095521677051
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.06032095521677051
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.06032095521677051
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.06032095521677051
SNEDDON SYNDROME	0.000915751	0.06032095521677051
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.06032095521677051
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.06032095521677051
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.06032095521677051
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.06032095521677051
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.06032095521677051
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.06032095521677051
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.06032095521677051
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.06032095521677051
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.06032095521677051
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.06032095521677051
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.06032095521677051
PAPILLORENAL SYNDROME	0.000915751	0.06032095521677051
FLYNN-AIRD SYNDROME	0.000915751	0.06032095521677051
EPILEPSY-TELANGIECTASIA	0.000915751	0.06032095521677051
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.06032095521677051
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.06032095521677051
MENKES DISEASE	0.000915751	0.06032095521677051
EPISODIC ATAXIA, TYPE 6	0.000915751	0.06032095521677051
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.06032095521677051
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.06032095521677051
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.06032095521677051
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.06032095521677051
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.06032095521677051
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.06032095521677051
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.06032095521677051
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.06032095521677051
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.06032095521677051
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.06032095521677051
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.06032095521677051
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.06032095521677051
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.06032095521677051
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.06032095521677051
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.06032095521677051
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.06032095521677051
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.06032095521677051
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.06032095521677051
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.06032095521677051
COWDEN SYNDROME 5; CWS5	0.000915751	0.06032095521677051
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.06032095521677051
PARIETAL FORAMINA	0.000915751	0.06032095521677051
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.06032095521677051
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.06032095521677051
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.06032095521677051
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.06032095521677051
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.06032095521677051
CYCLIC VOMITING SYNDROME	0.000915751	0.06032095521677051
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.06032095521677051
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.06032095521677051
KEUTEL SYNDROME; KTLS	0.000915751	0.06032095521677051
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.06032095521677051
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.06032095521677051
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.06032095521677051
HYPERPROLINEMIA, TYPE II	0.000915751	0.06032095521677051
RAMON SYNDROME	0.000915751	0.06032095521677051
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.06032095521677051
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.000915751	0.06032095521677051
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.06032095521677051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.06032095521677051
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.06032095521677051
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.06032095521677051
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.06032095521677051
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.000915751	0.06032095521677051
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.06032095521677051
HUNTINGTON DISEASE; HD	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.06032095521677051
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.06032095521677051
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.06032095521677051
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.06032095521677051
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.000915751	0.06032095521677051
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.06032095521677051
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.06032095521677051
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.06032095521677051
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.06032095521677051
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.06032095521677051
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.06032095521677051
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.06032095521677051
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.06032095521677051
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.06032095521677051
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.000915751	0.06032095521677051
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.06032095521677051
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.06032095521677051
DIAMINOPENTANURIA	0.000915751	0.06032095521677051
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.06032095521677051
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.06032095521677051
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000915751	0.06032095521677051
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.06032095521677051
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.06032095521677051
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.06032095521677051
INCONTINENTIA PIGMENTI; IP	0.000915751	0.06032095521677051
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.06032095521677051
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.06032095521677051
PERRAULT SYNDROME 3	0.000915751	0.06032095521677051
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.06032095521677051
1p36 microdeletion syndrome	0.000915751	0.06032095521677051
AUTISM	0.000915751	0.06032095521677051
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.06032095521677051
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.06032095521677051
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.06032095521677051
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.06032095521677051
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.06032095521677051
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.06032095521677051
THYROCEREBRORETINAL SYNDROME	0.000915751	0.06032095521677051
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.06032095521677051
DARIER-WHITE DISEASE; DAR	0.000915751	0.06032095521677051
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.06032095521677051
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.06032095521677051
GURRIERI SYNDROME	0.000915751	0.06032095521677051
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000915751	0.06032095521677051
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.06032095521677051
Fabry disease	0.000915751	0.06032095521677051
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.06032095521677051
METACHROMATIC LEUKODYSTROPHY	0.000915751	0.06032095521677051
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.06032095521677051
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000915751	0.06032095521677051
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000915751	0.06032095521677051
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000915751	0.06032095521677051
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.06032095521677051
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.06032095521677051
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.06032095521677051
THREONINEMIA	0.000915751	0.06032095521677051
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.06032095521677051
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.06032095521677051
GAPO SYNDROME; GAPOS	0.000915751	0.06032095521677051
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.06032095521677051
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.06032095521677051
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.06032095521677051
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.06032095521677051
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.06032095521677051
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.06032095521677051
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000915751	0.06032095521677051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.000915751	0.06032095521677051
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.06032095521677051
TAY-SACHS DISEASE; TSD	0.000915751	0.06032095521677051
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.06032095521677051
TENORIO SYNDROME; TNORS	0.000915751	0.06032095521677051
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.06032095521677051
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.06032095521677051
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.06032095521677051
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.06032095521677051
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.06032095521677051
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.06032095521677051
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.06032095521677051
KIFAFA SEIZURE DISORDER	0.000915751	0.06032095521677051
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.06032095521677051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.06032095521677051
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.06032095521677051
Angelman syndrome (Type 1)	0.000915751	0.06032095521677051
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.06032095521677051
COHEN SYNDROME	0.000915751	0.06032095521677051
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.06032095521677051
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.06032095521677051
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000915751	0.06032095521677051
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.06032095521677051
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.06032095521677051
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.06032095521677051
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.06032095521677051
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.06032095521677051
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.06032095521677051
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.06032095521677051
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.06032095521677051
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.06032095521677051
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.06032095521677051
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.06032095521677051
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.06032095521677051
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.06032095521677051
Wolf-Hirschhorn Syndrome	0.000915751	0.06032095521677051
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.06032095521677051
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.06032095521677051
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.06032095521677051
NEURAMINIDASE DEFICIENCY	0.000915751	0.06032095521677051
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.06032095521677051
LISSENCEPHALY 3; LIS3	0.000915751	0.06032095521677051
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.06032095521677051
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.06032095521677051
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.06032095521677051
2q33.1 deletion syndrome	0.000915751	0.06032095521677051
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.06032095521677051
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.06032095521677051
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.06032095521677051
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.06032095521677051
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.06032095521677051
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.06032095521677051
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.06032095521677051
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.06032095521677051
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.06032095521677051
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.06032095521677051
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.06032095521677051
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.06032095521677051
STURGE-WEBER SYNDROME	0.000915751	0.06032095521677051
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.06032095521677051
CROUZON SYNDROME	0.000915751	0.06032095521677051
Angelman syndrome (Type 2)	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.06032095521677051
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.06032095521677051
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.06032095521677051
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.06032095521677051
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.06032095521677051
HYPERLYSINEMIA, TYPE I	0.000915751	0.06032095521677051
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.06032095521677051
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.06032095521677051
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.06032095521677051
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.06032095521677051
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.06032095521677051
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.06032095521677051
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.06032095521677051
FOUNTAIN SYNDROME	0.000915751	0.06032095521677051
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000915751	0.06032095521677051
HYPER-BETA-ALANINEMIA	0.000915751	0.06032095521677051
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.055586909902624985
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.055586909902624985
JOUBERT SYNDROME 7	0.000843882	0.055586909902624985
ALAZAMI-YUAN SYNDROME	0.000843882	0.055586909902624985
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.055586909902624985
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.055586909902624985
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.055586909902624985
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.055586909902624985
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.055586909902624985
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.055586909902624985
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.055586909902624985
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.055586909902624985
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.055586909902624985
REVESZ SYNDROME	0.000843882	0.055586909902624985
JOUBERT SYNDROME 25	0.000843882	0.055586909902624985
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.055586909902624985
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.055586909902624985
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.055586909902624985
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.055586909902624985
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.055586909902624985
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.055586909902624985
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.055586909902624985
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.055586909902624985
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.055586909902624985
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.055586909902624985
SENIOR-LOKEN SYNDROME 9	0.000843882	0.055586909902624985
JOUBERT SYNDROME 15	0.000843882	0.055586909902624985
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.055586909902624985
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.055586909902624985
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.055586909902624985
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.055586909902624985
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.055586909902624985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.055586909902624985
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.055586909902624985
HOLOPROSENCEPHALY 11	0.000843882	0.055586909902624985
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.055586909902624985
JOUBERT SYNDROME 24	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.055586909902624985
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.055586909902624985
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.055586909902624985
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.055586909902624985
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.055586909902624985
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.055586909902624985
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.055586909902624985
XIA-GIBBS SYNDROME	0.000843882	0.055586909902624985
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.055586909902624985
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000843882	0.055586909902624985
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.055586909902624985
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.055586909902624985
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.055586909902624985
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.055586909902624985
MECKEL SYNDROME 13; MKS13	0.000843882	0.055586909902624985
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.055586909902624985
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.055586909902624985
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.055586909902624985
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.055586909902624985
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.055586909902624985
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.055586909902624985
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.055586909902624985
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.055586909902624985
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.055586909902624985
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.055586909902624985
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.055586909902624985
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.055586909902624985
JOUBERT SYNDROME 21	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.055586909902624985
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.055586909902624985
FORSYTHE-WAKELING SYNDROME; FWS	0.000843882	0.055586909902624985
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.055586909902624985
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.055586909902624985
CURRARINO SYNDROME	0.000843882	0.055586909902624985
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.055586909902624985
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.055586909902624985
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.055586909902624985
Cerebral creatine deficiency syndrome 3	0.000843882	0.055586909902624985
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.055586909902624985
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.055586909902624985
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.055586909902624985
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.055586909902624985
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.055586909902624985
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.055586909902624985
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.055586909902624985
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.055586909902624985
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.055586909902624985
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.055586909902624985
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.055586909902624985
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.055586909902624985
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.055586909902624985
Bardet-Biedl syndrome 2	0.000843882	0.055586909902624985
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.055586909902624985
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.055586909902624985
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000843882	0.055586909902624985
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.055586909902624985
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.055586909902624985
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.055586909902624985
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.055586909902624985
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.055586909902624985
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.055586909902624985
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.055586909902624985
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.055586909902624985
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.055586909902624985
JOUBERT SYNDROME 26	0.000843882	0.055586909902624985
HURLER SYNDROME	0.000843882	0.055586909902624985
HYDROXYKYNURENINURIA	0.000843882	0.055586909902624985
JOUBERT SYNDROME 28	0.000843882	0.055586909902624985
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.055586909902624985
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.055586909902624985
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.055586909902624985
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.055586909902624985
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.055586909902624985
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.055586909902624985
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.055586909902624985
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000843882	0.055586909902624985
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.055586909902624985
LOWRY-MACLEAN SYNDROME	0.000843882	0.055586909902624985
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.055586909902624985
JOUBERT SYNDROME 2	0.000843882	0.055586909902624985
FRIAS SYNDROME	0.000843882	0.055586909902624985
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.055586909902624985
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.055586909902624985
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.055586909902624985
NOONAN SYNDROME 9; NS9	0.000843882	0.055586909902624985
CDAGS SYNDROME	0.000843882	0.055586909902624985
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.055586909902624985
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.055586909902624985
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.055586909902624985
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.055586909902624985
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.055586909902624985
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.055586909902624985
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.055586909902624985
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.055586909902624985
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.055586909902624985
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.055586909902624985
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.055586909902624985
NOONAN SYNDROME 11; NS11	0.000843882	0.055586909902624985
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.055586909902624985
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.055586909902624985
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.055586909902624985
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.055586909902624985
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.055586909902624985
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.055586909902624985
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.055586909902624985
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.055586909902624985
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.055586909902624985
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.055586909902624985
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.055586909902624985
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.055586909902624985
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.055586909902624985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.055586909902624985
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.055586909902624985
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.055586909902624985
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.055586909902624985
CULLER-JONES SYNDROME; CJS	0.000843882	0.055586909902624985
RAHMAN SYNDROME	0.000843882	0.055586909902624985
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.055586909902624985
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.055586909902624985
AUSTRALIA ANTIGEN	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.055586909902624985
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.055586909902624985
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.055586909902624985
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.055586909902624985
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.055586909902624985
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.055586909902624985
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.055586909902624985
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.055586909902624985
#300555 DENT DISEASE 2	0.000843882	0.055586909902624985
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.055586909902624985
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.055586909902624985
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.055586909902624985
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.055586909902624985
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.055586909902624985
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000843882	0.055586909902624985
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.055586909902624985
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.055586909902624985
300270 ADRENOMYODYSTROPHY	0.000843882	0.055586909902624985
MEVALONIC ACIDURIA; MEVA	0.000843882	0.055586909902624985
NETHERTON SYNDROME; NETH	0.000843882	0.055586909902624985
JOUBERT SYNDROME 6	0.000843882	0.055586909902624985
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000843882	0.055586909902624985
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.055586909902624985
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.055586909902624985
WAARDENBURG-SHAH SYNDROME	0.000843882	0.055586909902624985
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.055586909902624985
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000843882	0.055586909902624985
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.055586909902624985
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.055586909902624985
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.055586909902624985
CURRY-JONES SYNDROME	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.055586909902624985
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000843882	0.055586909902624985
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.055586909902624985
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.055586909902624985
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.055586909902624985
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.055586909902624985
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.055586909902624985
SEPTOOPTIC DYSPLASIA	0.000843882	0.055586909902624985
MEIER-GORLIN SYNDROME 7	0.000843882	0.055586909902624985
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.055586909902624985
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.055586909902624985
Leukotriene C4 synthase deficiency	0.000843882	0.055586909902624985
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.055586909902624985
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.055586909902624985
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.055586909902624985
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.055586909902624985
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.055586909902624985
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.055586909902624985
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.055586909902624985
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.055586909902624985
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.055586909902624985
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.055586909902624985
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.055586909902624985
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.055586909902624985
NAVAJO NEUROHEPATOPATHY	0.000843882	0.055586909902624985
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.055586909902624985
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.055586909902624985
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.055586909902624985
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.055586909902624985
LIG4 SYNDROME	0.000843882	0.055586909902624985
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.055586909902624985
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.055586909902624985
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.055586909902624985
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.055586909902624985
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.055586909902624985
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.055586909902624985
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.055586909902624985
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.055586909902624985
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.055586909902624985
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.055586909902624985
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.055586909902624985
MUCOLIPIDOSIS IV; ML4	0.000843882	0.055586909902624985
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.055586909902624985
ALSTROM SYNDROME; ALMS	0.000843882	0.055586909902624985
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.055586909902624985
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.055586909902624985
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.055586909902624985
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.055586909902624985
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.055586909902624985
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.055586909902624985
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.055586909902624985
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.055586909902624985
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.055586909902624985
JOUBERT SYNDROME 8	0.000843882	0.055586909902624985
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.055586909902624985
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.055586909902624985
Jawad syndrome	0.000843882	0.055586909902624985
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.055586909902624985
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.055586909902624985
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.055586909902624985
ARIMA SYNDROME	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.055586909902624985
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.055586909902624985
SECKEL SYNDROME 9; SCKL9	0.000843882	0.055586909902624985
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.055586909902624985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.055586909902624985
OPTIC ATROPHY 11; OPA11	0.000843882	0.055586909902624985
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.055586909902624985
YOU-HOOVER-FONG SYNDROME; YHFS	0.000843882	0.055586909902624985
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.055586909902624985
SECKEL SYNDROME 8; SCKL8	0.000843882	0.055586909902624985
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.055586909902624985
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.055586909902624985
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.055586909902624985
OROTIC ACIDURIA	0.000843882	0.055586909902624985
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.055586909902624985
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.055586909902624985
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.055586909902624985
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.055586909902624985
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.055586909902624985
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.055586909902624985
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.055586909902624985
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.055586909902624985
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.055586909902624985
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.055586909902624985
JOUBERT SYNDROME 27	0.000843882	0.055586909902624985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.055586909902624985
NOONAN SYNDROME 2; NS2	0.000843882	0.055586909902624985
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.055586909902624985
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.055586909902624985
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.055586909902624985
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.055586909902624985
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.055586909902624985
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.055586909902624985
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.055586909902624985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.055586909902624985
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.055586909902624985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.055586909902624985
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.055586909902624985
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.055586909902624985
PELLAGRA-LIKE SYNDROME	0.000843882	0.055586909902624985
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.055586909902624985
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.055586909902624985
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.055586909902624985
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.055586909902624985
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.055586909902624985
